Compare GXO & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GXO | SHC |
|---|---|---|
| Founded | 2021 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.5B |
| IPO Year | 2021 | 2020 |
| Metric | GXO | SHC |
|---|---|---|
| Price | $49.14 | $15.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 7 |
| Target Price | ★ $67.91 | $20.33 |
| AVG Volume (30 Days) | 1.2M | ★ 2.4M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 68.75 |
| EPS | 0.03 | ★ 0.09 |
| Revenue | ★ $13,178,000,000.00 | $1,163,617,000.00 |
| Revenue This Year | $6.81 | $7.51 |
| Revenue Next Year | $5.95 | $6.00 |
| P/E Ratio | $1,657.67 | ★ $174.89 |
| Revenue Growth | ★ 12.55 | 5.74 |
| 52 Week Low | $45.40 | $10.94 |
| 52 Week High | $66.85 | $19.85 |
| Indicator | GXO | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 47.99 | 49.54 |
| Support Level | $48.58 | $15.11 |
| Resistance Level | $51.35 | $16.47 |
| Average True Range (ATR) | 1.47 | 0.49 |
| MACD | 0.15 | -0.04 |
| Stochastic Oscillator | 38.96 | 44.64 |
GXO Logistics Inc is a contract logistics company. Its revenue is diversified across numerous verticals and customers, including many multinational corporations. It provides warehousing and distribution, order fulfillment, e-commerce, reverse logistics, and other supply chain services differentiated by its ability to deliver technology-enabled, customized solutions at scale. Geographically, it generates revenue from the United Kingdom, the United States, the Netherlands, France, Spain, Italy, and other countries, and derives the majority of its revenue from the United Kingdom.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.